
Capricor Therapeutics Inc Investor Relations Material
Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders
Latest company events
Ticker symbol
CAPR
Country
United States of America